The Efficacy of Cinnamon Extract ( Cinnamomum burmannii ) on Reducing Staging Acute Kidney Injury in Ischemia Reperfusion (IR) Model
DOI:
https://doi.org/10.32539/bsm.v5i1.203Keywords:
Cinnamomum Burmannii, Acute Kidney Injury, Ischemia ReperfusionAbstract
A B S T R A C T
Introduction. Acute kidney injury (AKI) is defined as sudden decline in the
glomerular filtration rate, resulting in the retention of nitrogenous wastes, such as
urea and creatinine in plasma. Cinnamomum burmannii is known as a anti-
inflammatory renoprotective agent, although the precise mechanism is not well
understood. This study aimed to elucidate the effectiveness of Cinnamomum
burmannii extract in decreasing creatinine level of acute kidney injury Ischemia
reperfusion (IR) model. Method. We performed Ischemia reperfusion (IR) in male
Wistar rat to induce acute kidney injury. The rat (n=30) were divided into six groups:
IR, 1 group treated with methylprednisolone as a control (IR+M), 3 groups treated
with different oral Cinnamomum burmannii extract doses (50mg/kg (IR+EKM1),
100mg/kg (IR+EKM2), and 200 mg/kg (IR+EKM3), and a Sham operation (SO)
group. AKI stage reduction based on serum creatinine levels, before and after
modeling, before and after the cinnamon extract intervention. Creatinine levels were
quntified by spectrophotometry and analyzed by SPSS. Result. Cinnamomum
burmannii extract lowers creatinine levels; significant (P <0.05). 200 mg / kgbb is
the effective dose of lowering creatinine levels in the IR model. Conclusion.
Cinnamomum burmannii extract reduced serum creatinine levels associated with
decreased acute renal staging in the IR model.
Authors
- Evi Lusiana1*
- Nia Savitri Tamzil1
- Desi Oktarina2
- 1Department of Pharmacology, Faculty of Medicine, University of Sriwijaya, Indonesia
- 2Department of Clinical Pathology, Faculty of Medicine, University of Sriwijaya, Indonesia
Corresponding author Evi Lusiana — mrs.evilusiana@gmail.com
Article history
- Submitted
- Accepted
- Published
Downloads
Published
Issue
Section
License
Copyright and licensing
Copyright in each article remains with the author(s). Authors grant Bioscientia Medicina: Journal of Biomedicine and Translational Research a non-exclusive right of first publication and the right to identify itself as the original publisher. No exclusive transfer of copyright is required.
All articles are published under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA 4.0): https://creativecommons.org/licenses/by-nc-sa/4.0/. Users may copy, redistribute, remix, transform, and build upon the material for non-commercial purposes, provided appropriate attribution is given, a link to the license is supplied, changes are indicated, and adaptations are distributed under the same license.
The license applies to the article's scholarly content unless a credit line states otherwise. Third-party material may be subject to separate rights. Authors retain patent, trademark, moral, and research-data rights. The copyright year follows the article's publication date.
